Medical device company, Senzime ( OTCQX:SNZZF ) secured a purchasing contract with a children's hospital system in the U.S. for its TetraGraph quantitative neuromuscular monitoring system.

The contract was awarded following a comprehensive competitive evaluation and once fully implemented, the TetraGraph system will be utilized in over 40 operating rooms, supporting more than 30,000 surgeries annually. More on Senzime AB Historical earnings data for Senzime AB (publ) Financial information for Senzime AB (publ).